Managing uncontrolled hemorrhage in trauma and surgery: a novel and promising approach.
Hardy JF
Can J Anaesth 2002;49(10):S4-S6.
Review by
Recombinant activated factor VII: its mechanism of action and role in the control of hemorrhage.
Allen GA, Hoffman M, Roberts HR, Monroe DM
Can J Anaesth 2002;49(10):S7-S14.
Review by Aldouri M
Efficacy of recombinant factor VIIa administered by continuous infusion to haemophilia patients with inhibitors.
Mauser-Bunschoten EP, Koopman MMW, Goede-Bolder ADE, et al.
Haemophilia 2002;8(5):649-656.
Review by M. Aldouri
Continuous infusion of coagulation factor products.
Stachnik JM, Gabay MP
Ann Pharmacother 2002;36(5):882-891.
Review by
Experience with use of recombinant activated factor VII.
Divanon F, Hecquard C, Borel-Derlon A
J Clin Pharm Ther 2002;27(2):133-138.
Review by
Successful use of recombinant factor VIIa in a patient with inhibitor secondary to severe factor XI deficiency.
Lawler P, White B, Pye S, et al.
Haemophilia 2002;8(2):145-148.
Review by
Case report on recombinant coagulation factor VIIa in the treatment of three haemophilia A patients with inhibitors in Singapore.
Ng HJ, Lee LH
Ann Acad Med Singapore 2002;31(2):241-244.
Review by Aldouri M
Potential role for rFVIIa in transfusion medicine.
Hedner U, Erhardtsen E
Transfusion 2002;42(1):114-124.
Review by Aldouri M
Use of recombinant factor VII in hepatology.
Romero Castro R, Barroso Relinque N, Caunedo Alvarez AC, et al.
Rev Esp Enferm Dig 2001;93(10):664-668.
Review by
Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures.
Cooper HA, Jones CP, Campion E, Roberts HR, Hedner U
Haemophilia 2001;7(5):517-522.
Review by M. Aldouri
Use of recombinant factor VIIa in hereditary bleeding disorders.
Poon MC
Curr Opin Hematol 2001;8(5):312-318.
Review by M. Aldouri
Recombinant activated factor VII for adjunctive hemorrhage control in trauma.
Martinowitz U, Kenet G, Segal E, et al.
J Trauma 2001;51(3):431-438.
Review by M. Aldouri